June 20th 2025
Trendy manicures like Russian nails and 3D art may complicate diagnosis or cause damage, making them important for dermatologists to recognize.
Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient
July 26, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management
View More
Burst CME: Targeted Therapy for Optimal Psoriasis Management
View More
Rejuvenating the aging perioral region
December 1st 2006Toronto - There are numerous procedures and techniques at the disposal of the surgeon for addressing the aging perioral features, according to Ross A. Clevens M.D., F.A.C.S., head plastic surgeon at The Center for Facial Cosmetic Surgery in Melbourne, Merritt Island, Fla. He discussed different techniques on how to best rejuvenate and sculpt the aging perioral complex region, at the American Academy of Facial Plastic and Reconstructive Surgery, here.
Long-suffering rosacea patient asks, 'Doctors, please listen to your patients'
December 1st 2006In his Guest Commentary "Managing rosacea; practitioners discuss trends" (September 2006), Dr. William Baum presents his findings after moderating advisory panels across the country consisting of specialists talking about the many facets of rosacea.
IL-1a, Propionibacterium acnes and retinoids comprise key players
November 1st 2006Retinoids affect the inflammatory pathways of acne lesion development indirectly via their ability to normalize hyperkeratinization. However, they also exert direct immunomodulatory effects by competing with transcription factors like AP-1.
How best to communicate with ...
November 1st 2006"Usually, when kids go to the clinic, especially if they're little, they get so many vaccinations that when one takes off their clothes, they think they're getting a shot," explains Papri Sarkar, M.D., a third-year resident in Harvard's dermatology training program. "Also, I try to avoid using gloves unless they're clinically necessary."
Anatomy lessons, guiding the bill
November 1st 2006I do a lot of complicated skin cancer repairs and I have never really been very sure of the correct way to code for this particular type of closure: the purse string repair. I have spoken with several of my colleagues and everyone seems to be coding this differently. I have also scoured the CPT book with no real hints at what I should code. What do you think?
BBL, laser combination may maximize hair removal outcomes
November 1st 2006National report - Both the 1064 nm Nd:YAG laser and broadband light (BBL) source are safe and effective modalities for hair removal, but even better results may be achieved using them in combination, according to the results of a study undertaken by Michael H. Gold, M.D., medical director, Gold Skin Care Center and The Laser and Rejuvenation Center, Nashville, Tenn.
Botulinum toxin consistently keeps sweat at bay
November 1st 2006National report - Patients with axillary hyperhidrosis derive significant quality-of-life benefits from treatment with botulinum toxin type A (Botox, Allergan), and the magnitude of improvement remains consistent with repeated injections over a period of at least three years, according to the results of an open-label extension study.